Ultralife (ULBI) Expected to Release Earnings on Thursday

Ultralife (NASDAQ:ULBI) is anticipated to release its Q2 2026 results before the market opens on Thursday, July 23rd. Analysts expect the company to announce earnings of $0.19 per share and revenue of $55.00 million for the quarter. Interested persons are encouraged to explore the company’s upcoming Q2 2026 earning results page for the latest details on the call scheduled for Thursday, August 6, 2026 at 12:00 PM ET.

Ultralife (NASDAQ:ULBI) last posted its quarterly earnings results on Friday, May 8th. The technology company reported ($0.03) EPS for the quarter, missing the consensus estimate of $0.15 by ($0.18). Ultralife had a positive return on equity of 1.15% and a negative net margin of 4.37%.The company had revenue of $47.45 million for the quarter, compared to analyst estimates of $52.40 million.

Ultralife Stock Performance

Shares of ULBI opened at $5.27 on Tuesday. The company has a market capitalization of $87.80 million, a PE ratio of -10.54 and a beta of 0.78. The company has a debt-to-equity ratio of 0.34, a quick ratio of 1.23 and a current ratio of 2.56. The company’s 50 day moving average price is $6.31 and its 200 day moving average price is $6.41. Ultralife has a 52 week low of $4.90 and a 52 week high of $9.52.

Wall Street Analyst Weigh In

Separately, Weiss Ratings lowered shares of Ultralife from a “sell (d+)” rating to a “sell (d)” rating in a research note on Friday, June 12th. One analyst has rated the stock with a Sell rating, According to MarketBeat.com, Ultralife has a consensus rating of “Sell”.

Insider Buying and Selling at Ultralife

In other news, Director Bradford T. Whitmore purchased 67,302 shares of the business’s stock in a transaction dated Tuesday, May 26th. The stock was bought at an average cost of $6.81 per share, with a total value of $458,326.62. Following the purchase, the director directly owned 2,050,637 shares of the company’s stock, valued at approximately $13,964,837.97. This trade represents a 3.39% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Over the last three months, insiders bought 108,878 shares of company stock worth $714,928. 42.90% of the stock is owned by company insiders.

Hedge Funds Weigh In On Ultralife

Hedge funds have recently added to or reduced their stakes in the company. Janney Montgomery Scott LLC raised its position in Ultralife by 6.8% during the fourth quarter. Janney Montgomery Scott LLC now owns 507,800 shares of the technology company’s stock valued at $2,905,000 after acquiring an additional 32,133 shares in the last quarter. Arrowstreet Capital Limited Partnership lifted its stake in Ultralife by 210.8% in the third quarter. Arrowstreet Capital Limited Partnership now owns 219,018 shares of the technology company’s stock valued at $1,494,000 after acquiring an additional 148,542 shares during the last quarter. Raymond James Financial Inc. grew its position in Ultralife by 14.5% in the second quarter. Raymond James Financial Inc. now owns 116,085 shares of the technology company’s stock worth $1,042,000 after acquiring an additional 14,667 shares in the last quarter. Ancora Advisors LLC grew its position in Ultralife by 24.3% in the third quarter. Ancora Advisors LLC now owns 105,321 shares of the technology company’s stock worth $718,000 after acquiring an additional 20,562 shares in the last quarter. Finally, Citadel Advisors LLC increased its stake in shares of Ultralife by 78.9% during the 3rd quarter. Citadel Advisors LLC now owns 80,921 shares of the technology company’s stock worth $552,000 after purchasing an additional 35,695 shares during the last quarter. Institutional investors and hedge funds own 30.68% of the company’s stock.

About Ultralife

Ultralife Corporation (NASDAQ: ULBI) develops, manufactures and sells a broad range of energy and communications products for defense, medical, automotive and consumer electronics markets. The company operates through two primary segments: Power Systems and Communications Systems. In its Power Systems segment, Ultralife produces lithium-ion rechargeable cells and battery packs, primary lithium batteries, alkaline and rechargeable battery packs, chargers and battery accessories designed to meet demanding performance and safety requirements.